rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Thomas S. Bremner

Director

Company insider

Files Form 4 as: Director, BillionToOne.

In numbers

Trades disclosed
59
Buys
1
Sells
0
Bought
$2.5M
Sold
$0
Companies
1
Companies where not an officer
1
First trade
6 Nov 2025
Last trade
10 Jun 2026
Last filed
12 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BLLN BillionToOneDirector · Diagnostics & Labs · last 10 Jun 20261 buy · 0 sells

Activity over time

1 Nov 2025 – 1 Oct 2026
01Nov 25Feb 26May 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Jun 2026filed 12 Jun 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code A—3,017 at $0.00filing
10 Jun 2026filed 12 Jun 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code A—3,017 at $0.00filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—1,352filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—114,117filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—16,747filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—20,224filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—121,688filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—17,858filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—16,165filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—1,562filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—131,888filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—19,355filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—23,466filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—1,864filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—157,404filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—23,100filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—87,550filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—652filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—55,091filing
7 Nov 2025filed 10 Nov 2025BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code C—8,084filing

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Thomas P. LynchOfficer · Officer at BillionToOne, filing Form 4 there in the last year
Oguzhan AtayChairman and CEO · Chairman and CEO at BillionToOne, filing Form 4 there in the last year
John Roderick ten BoschSVP of Laboratory Operations · SVP of Laboratory Operations at BillionToOne, filing Form 4 there in the last year
David TsaoChief Technology Officer · Chief Technology Officer at BillionToOne, filing Form 4 there in the last year
Shan Riku SakakibaraChief Product Officer · Chief Product Officer at BillionToOne, filing Form 4 there in the last year